Trial intelligence / Profile preview

Topical Tranexamic Acid in Posterior Spine Surgery

NCT02063035Phase 4Completed

Sponsor
Massachusetts General Hospital
Start
Aug 2012
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in lumbar spinal stenosis (LSS) and thoracic spinal stenosis (TSS) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Change in Hemoglobin Level From Preoperative Appointment to Postoperative Hospital Discharge. Started Aug 2012; status: completed.

02

Drugs

tranexamic acid
03

Conditions

lumbar spinal stenosis (LSS)thoracic spinal stenosis (TSS)

Beyond the preview

Go deeper on NCT02063035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02063035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call